This study will see if the serratus posterior superior intercostal plane (SPSIP) block improves postoperative recovery after breast cancer surgery. you would be randomly assigned to one of two groups.
Official registry: https://clinicaltrials.gov/study/NCT07843212 · Mucahide Emine Fidancı Kuas · enrollment listed as 80
This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
If you join, the listed intervention(s) are Serratus posterior superior intercostal plane block, or Sham SPSIP Procedure. The registry lists allocation as randomized. This study will see if the serratus posterior superior intercostal plane (SPSIP) block improves postoperative recovery after breast cancer surgery.
They plan to enroll about 80 people at Çorum. Taking part typically means a procedure as part of the study plus check-ins.
Effects of Serratus Posterior Superior Intercostal Plane Block on Perioperative Inflammatory Response and TLR4-Mediated Innate Immune Activation in Breast Cancer Surgery: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial
Interventions: Serratus posterior superior intercostal plane block, Sham SPSIP Procedure
Primary outcome (registry wording): Change in serum TLR4 concentration from baseline to 24 hours after surgery
Mucahide Emine Fidancı Kuas, MD
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
This study will collect blood from patients with cancer to study the level of cells which decrease the immune response (suppressor cells) before and after chemotherapy. Patients 18 years of age and older with cancer may participate.
NCT00034216 · Official ClinicalTrials.gov record · National Cancer Institute (NCI)
This study aims to provide long-term follow-up care of patients previously enrolled in a vaccine study that involved poxviral vectors. Vectors are sequences of genetic material that can be used to introduce specific genes into genetic makeup.
NCT00451022 · Official ClinicalTrials.gov record · National Cancer Institute (NCI)
Background: The NCI Surgery Branch has developed an experimental therapy that involves taking white blood cells from patients' tumors, growing them in the laboratory in large numbers, and then giving the cells back to the patient. These cells are called Tumor Infiltrating Lymphocytes, or TIL and we have given this type of treatment to over 200 patients with melanoma.
NCT01174121 · Official ClinicalTrials.gov record · National Cancer Institute (NCI)
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary